Jump to content

Talk:Post-LASIK ectasia

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
[edit]

Unable to find a link from the FDA?

"On July 19, 2016, FDA has approved Avedro's KXL system and two photoenhancers for the treatment of corneal ectasia following refractive surgery.[1][2]" Doc James (talk · contribs · email) 18:19, 4 August 2016 (UTC)[reply]

See this document on FDA. it mentions "recent major changes" in July 2016 for "indications and usage", "PHOTREXA VISCOUS and PHOTREXA are photoenhancers indicated for use with the KXL System in corneal collagen cross-linking for the treatment of progressive keratoconus (1.1) and corneal ectasia following refractive surgery (1.2)". k18s (talk) 02:37, 6 August 2016 (UTC)[reply]

References

  1. ^ "FDA approves Avedro's cross-linking system for corneal ectasia following refractive surgery". July 19, 2016.
  2. ^ "Avedro Receives Additional Indication for Photrexa® Viscous, Photrexa® and the KXL® System for the Treatment of Corneal Ectasia following Refractive Surgery". avedro.com. Jul 19, 2016.